BRCA1 and ovarian carcinoma: For example, one of the studies with greater mutation frequencies for BRCA1/2 (33.3%) included not only index patients but also their relatives, increasing the chances of detecting variants if we take into account that all these patients belonged to families with several breast/ovarian cancers (Miramar et al. 2008).